Blossom Ridge and Bloom Value join CMS ACCESS Model

By AI, Created 4:35 PM UTC, May 18, 2026, /AGP/ – Blossom Ridge Medical Inc. and Bloom Value said they are participating together in CMS’s ACCESS Model, a 10-year Medicare initiative focused on technology-enabled chronic disease management. The partnership pairs clinical care and AI infrastructure ahead of the model’s July 5, 2026 launch, with acceptance across all four tracks contingent on CMS requirements being completed.

Why it matters: - The ACCESS Model ties Medicare reimbursement to measurable health outcomes instead of service volume. - The model is built for chronic disease management in conditions that affect more than two-thirds of Medicare beneficiaries, including hypertension, diabetes, chronic kidney disease, chronic pain, depression and anxiety. - Blossom Ridge Medical Inc. and Bloom Value are positioning themselves to compete in a Medicare payment model that rewards earlier detection, proactive intervention and traceable care delivery.

What happened: - Blossom Ridge Medical Inc., a Medicare-enrolled primary care clinic in Sacramento, California, and Bloom Value, a healthcare AI company, announced joint participation in CMS Innovation Center’s ACCESS Model. - The two organizations are working as a combined clinical and technology unit to meet the model’s operational, reporting and audit requirements. - Participation remains contingent on successful completion of all CMS model requirements before the July 5, 2026 launch. - Blossom Ridge and Bloom Value were accepted across all four ACCESS tracks: Early Cardio-Kidney-Metabolic (eCKM), Cardio-Kidney-Metabolic (CKM), Musculoskeletal (MSK) and Behavioral Health (BH). - The organizations said only a small number of the 150+ organizations in the inaugural national cohort received that across-all-tracks distinction.

The details: - ACCESS is a 10-year national CMS initiative called Advancing Chronic Care with Effective, Scalable Solutions. - The model covers conditions ranging from prediabetes and dyslipidemia to chronic musculoskeletal pain, depression and anxiety. - Blossom Ridge said the partnership supports whole-person care for its Medicare population. - CMS-defined clinical thresholds and CMS-aligned interoperability standards will be used to measure and report outcomes. - Blossom Ridge Medical Director Dr. Glenda Agustin said the model is designed to reward technology-enabled chronic disease management. - Dr. Agustin said Bloom Value’s AI platform helps analyze patient records, identify early-onset CKM and complex comorbidities, and act earlier. - Bloom Value’s FAST platform provides predictive chronic disease management support and earlier detection and intervention. - The FAST platform also supports eligibility tracking, outcome status management, period-based audit trails and CMS-aligned reporting workflows. - Bloom Value CEO Arun Hampapur said ACCESS shifts the focus from what care was delivered to whether health improved. - Hampapur said the FAST platform makes clinical decisions traceable, measurable and tied to outcomes. - Bloom Value describes FAST as an AI and machine learning platform that aims to improve financial and operational performance for healthcare organizations, including IPAs, MSOs, ACOs and health systems. - Blossom Ridge Medical Inc. is a Medicare-enrolled primary care clinic in Sacramento, California.

Between the lines: - The announcement signals an effort to combine clinical delivery with AI-enabled operations so the organizations can handle the model’s measurement and compliance burden. - Gaining acceptance across all four tracks may give Blossom Ridge and Bloom Value broader reach inside a Medicare program that spans both physical and behavioral health conditions. - The focus on interoperability, audit trails and outcomes reporting suggests CMS will scrutinize not just care quality, but whether providers can prove that quality with data.

What’s next: - Blossom Ridge and Bloom Value must complete all CMS requirements before the July 5, 2026 ACCESS launch. - If approved, the partnership will enter a Medicare model that could shape how chronic care is delivered and reimbursed over the next decade. - The organizations will need to show that AI-supported workflows can improve outcomes and withstand CMS reporting and audit expectations.

The bottom line: - Blossom Ridge and Bloom Value are betting that AI-driven chronic care execution can help providers meet the next generation of Medicare value-based care requirements.